Literature DB >> 17559744

Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.

M Happich1, L Breitscheidel, C Meisinger, M Ulbig, P Falkenstein, U Benter, J Watkins.   

Abstract

OBJECTIVE: To obtain epidemiological data on the prevalence of predefined stages of diabetic microvascular complications from a representative cross-section of patients with existing microvascular complications of type 1 or type 2 diabetes in Germany. RESEARCH DESIGN AND METHODS: A cross-sectional, retrospective study of medical records of 705 type 1 and 1910 type 2 adult diabetic patients with a diagnosis of retinopathy and/or peripheral neuropathy and/or nephropathy before 2002 and treated in 2002 in Germany.
RESULTS: Of 376 patients with type 1 diabetes having retinopathy, 59.3% had mild or moderate non-proliferative retinopathy without macular oedema, 27.1% had macular oedema, and 13.6% had severe retinopathy without macular oedema. In 862 patients with type 2 diabetes, the distribution of retinopathy/maculopathy classes was 56.8%, 35.5%, and 7.7%, respectively. Of 381 type 1 diabetes patients with observed peripheral neuropathy, 81.4% had sensorimotor neuropathy, 8.9% had diabetic foot conditions, and 9.7% had lower extremity amputations because of diabetes. In 1005 patients with type 2 diabetes, the distribution of neuropathy classes was 78.2%, 12.1%, and 9.7%, respectively. The proportions of patients with renal insufficiency in type 1 and type 2 diabetes groups were 15.3% versus 13.5%, respectively.
CONCLUSIONS: The study suggests that there are considerable proportions of patients with progressive stages of microvascular complications related to type 1 and type 2 diabetes in Germany. This underlines the importance of improvement of optimal quality of care and frequent screening for preventing late diabetic microvascular complications and the necessity of effective intervention strategies to tackle this major public health problem.

Entities:  

Mesh:

Year:  2007        PMID: 17559744     DOI: 10.1185/030079907X188215

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  3 in total

Review 1.  MicroRNAs as pharmacological targets in diabetes.

Authors:  Yiping Mao; Ramkumar Mohan; Shungang Zhang; Xiaoqing Tang
Journal:  Pharmacol Res       Date:  2013-06-28       Impact factor: 7.658

Review 2.  Role of microRNAs in diabetes.

Authors:  Xiaoqing Tang; Guiliang Tang; Sabire Ozcan
Journal:  Biochim Biophys Acta       Date:  2008-07-04

3.  Diabetic foot risk factors in type 2 diabetes patients: a cross-sectional case control study.

Authors:  Piotr Nehring; Beata Mrozikiewicz-Rakowska; Monika Krzyżewska; Agnieszka Sobczyk-Kopcioł; Rafał Płoski; Grażyna Broda; Waldemar Karnafel
Journal:  J Diabetes Metab Disord       Date:  2014-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.